開設賬戶
模擬帳戶
關於我們
即時報價及新聞
市場分析
財經日曆
每日市場分析
交易平台
下載及介紹
使用教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
繁
简
EN
客户登入
開設賬戶
模擬帳戶
繁
简
EN
客户登入
開設賬戶
模擬帳戶
關於我們
上志國際介紹
上志國際特點
即時報價及新聞
即時報價
即時新聞
市場分析
財經日曆
市場分析
交易平台
平台特點
平台教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
關於我們
交易細則
貴金屬市場
交易平台
市場分析
推廣和資訊
常見問題
聯絡我們
繁
简
EN
聯合石油數據庫JODI:沙特阿拉伯6月石油產品需求下降3.4萬桶/日,至263.3萬桶/日。6月原油產量環比增加56.2萬桶/日,至712.2萬桶/日。6月原油出口環比增加55.9萬桶/日,至399.3萬桶/日。6月國內煉廠原油加工量增加11.1萬桶/日,至249.7萬桶/日。
2026-08-20
聯合石油數據庫JODI:沙特阿拉伯6月石油產品需求下降3.4萬桶/日,至263.3萬桶/日。6月原油產量環比增加56.2萬桶/日,至712.2萬桶/日。6月原油出口環比增加55.9萬桶/日,至399.3萬桶/日。6月國內煉廠原油加工量增加11.1萬桶/日,至249.7萬桶/日。
返回
其他消息
2026-08-20
China’s National Medical Products Administration approved two new drugs: 1) Anfuliqita monoclonal antibody injection (subcutaneous), marketed as Yisaina, from Sansheng Guojian Pharmaceutical (Shanghai) Co., Ltd., for acute gouty arthritis in adults who are contraindicated, intolerant of, or unresponsive to NSAIDs and/or colchicine, or who are unsuitable for repeated steroid use. 2) Fumarate likangkepan capsules, marketed as HengYouDa, from Chengdu Shengdi Pharmaceutical Co., Ltd., approved under
China’s National Medical Products Administration approved two new drugs: 1) Anfuliqita monoclonal antibody injection (subcutaneous), marketed as Yisaina, from Sansheng Guojian Pharmaceutical (Shanghai) Co., Ltd., for acute gouty arthritis in adults who are contraindicated, intolerant of, or unresponsive to NSAIDs and/or colchicine, or who are unsuitable for repeated steroid use. 2) Fumarate likangkepan capsules, marketed as HengYouDa, from Chengdu Shengdi Pharmaceutical Co., Ltd., approved under the NMPA’s priority review for treatment of adult paroxysmal nocturnal hemoglobinuria (PNH) patients not previously treated with complement inhibitors.
2026-08-20
DALY: Recent employment and inflation data have not changed the outlook.
DALY: Recent employment and inflation data have not changed the outlook.
Chat with us
, powered by
LiveChat